Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 3/20 | 0.55 |
| ▸ | FABP3 | P05413 | 5/20 | 0.54 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.53 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.53 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | FABP4 | P15090 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27647304 | 1.00 | ENPP2 (0.55) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL3888681 | 0.92 | FABP3 (0.59) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL20484292 | 0.92 | FABP3 (0.59) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL22802111 | 0.92 | FABP3 (0.59) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL29086569 | 0.91 | DGKA (0.50) | ENPP2LPAR1LPAR4LPAR5LPAR2 | |
| SCHEMBL340006 | 0.87 | LPAR1 (0.55) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL10478921 | 0.87 | LPAR1 (0.55) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL28547666 | 0.87 | LPAR1 (0.55) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL193956 | 0.86 | LPAR1 (0.60) | ENPP2FABP3LPAR1LPAR4LPAR5 | |
| SCHEMBL18123890 | 0.86 | LPAR1 (0.60) | ENPP2FABP3LPAR1LPAR4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115485431-A | Treating agent for synthetic fiber, and method for treating synthetic fiber | 竹本油脂株式会社 | 2022-12-16 | — | — | CN | disclosed |
| CN-111764173-A | Treating agent for elastic fiber and elastic fiber | 竹本油脂株式会社 | 2020-10-13 | — | — | CN | disclosed |
| US-20130090237-A1 | PTEREDIN PENTANEDIOIC DERIVATIVE BASED NANOPARTICLES | MOHANTY SANAT (IN) | 2013-04-11 | — | — | US | disclosed |
| US-20120077022-A1 | HIERARCHICAL CHROMONIC STRUCTURES | 3M INNOVATIVE PROPERTIES COMPANY | 2012-03-29 | — | — | US | disclosed |
| US-8092710-B2 | Hierarchical chromonic structures | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-01-10 | — | — | US | disclosed |
| US-7993748-B2 | Multilayered chromonic structures | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-08-09 | — | — | US | disclosed |
| US-7981469-B2 | Encapsulated chromonic particles | 3M INNOVATIVE PROPERITES COMPANY (US) | 2011-07-19 | — | — | US | disclosed |
| US-20110020540-A1 | ENCAPSULATED CHROMONIC PARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2011-01-27 | — | — | US | disclosed |
| US-7824732-B2 | Encapsulated chromonic particles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-11-02 | — | — | US | disclosed |
| US-7718716-B2 | Chromonic nanoparticles containing bioactive compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-05-18 | — | — | US | disclosed |
| WO-2007047258-A1 | CHROMONIC NANOPARTICLES CONTAINING BIOACTIVE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007047307-A1 | METHOD FOR MAKING CHROMONIC NANOPARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070086965-A1 | Chromonic nanoparticles containing bioactive compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-19 | — | — | US | disclosed |
| US-20070086964-A1 | Method for making chromonic nanoparticles | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-19 | — | — | US | disclosed |
| US-20070042916-A1 | METHODS FOR IMPROVED POWER TRANSMISSION PERFORMANCE AND COMPOSITIONS THEREFOR | AFTON CHEMICAL CORPORATION | 2007-02-22 | — | — | US | disclosed |
| US-20070000745-A1 | METHODS FOR IMPROVED POWER TRANSMISSION PERFORMANCE | AFTON CHEMICAL CORPORATION | 2007-01-04 | — | — | US | disclosed |
| US-20070004603-A1 | METHODS FOR IMPROVED POWER TRANSMISSION PERFORMANCE AND COMPOSITIONS THEREFOR | AFTON CHEMICAL CORPORATION | 2007-01-04 | — | — | US | disclosed |
| EP-1739321-A2 | Methods for improved power transmission performance | Afton Chemical Corporation (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1739158-A2 | Methods for improved power transmission performance and lubricating compositions therefor | Afton Chemical Corporation (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1739159-A2 | Methods for improved power transmission performance and lubricating compositions therefor | Afton Chemical Corporation (US) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070086965-A1 | Chromonic nanoparticles containing bioactive compounds | RCC1, CTRL, CASP12 | ENPP2 3887/4885FABP3 1864/4885LPAR1 668/4885 |
| US-20070086964-A1 | Method for making chromonic nanoparticles | CA13, CHRNA6, CA12 | ENPP2 3149/4885FABP3 2000/4885LPAR1 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.